Tin protoporphyrin activates the oxidant-dependent NRF2-cytoprotective pathway and mitigates acute kidney injury

      Tin protoporphyrin (SnPP), a heme oxygenase (HO) inhibitor, can paradoxically protect against diverse forms of acute kidney injury (AKI). This study sought potential underlying mechanisms. CD-1 mice received intravenous SnPP, followed 4–18 hours later by a variety of renal biochemical, histologic, and genomic assessments. Renal resistance to ischemic-reperfusion injury (IRI) was also sought. SnPP was rapidly taken up by kidney and was confined to proximal tubules. Transient suppression of renal heme synthesis (decreased δ aminolevulinic acid synthase expression), a 2.5-fold increase in “catalytic” Fe levels and oxidant stress resulted (decreased glutathione; increased malondialdehyde, and protein carbonyl content). Nrf2 nuclear translocation (∼2x Nrf2 increase; detected by enzyme-linked immunosorbent assay, Western blotting), with corresponding activation of ∼20 Nrf2-sensitive genes (RNA-Seq) were observed. By 18 hours after SnPP injection, marked protection against IRI emerged. This represented “preconditioning”, not a direct SnPP effect, given that SnPP administered at the time of IRI exerted no protective effect. The importance of transient oxidant stress in SnPP “preconditioning” was exemplified by the following: (1) oxidant stress induced by a different mechanism (myoglobin injection) recapitulated SnPP's protective action; (2) GSH treatment blunted SnPP's protective influence; (3) SnPP raised cytoprotective heavy chain ferritin (Fhc), a response enhanced by exogenous Fe injection; and (4) SnCl2, a ∼35- to 50-fold HO-1 inducer (not inhibitor) evoked neither oxidant stress nor mitigated IRI (seemingly excluding HO-1 activity in SnPP's protective effect). SnPP specifically accumulates within proximal tubule cells; transient “catalytic” Fe overload and oxidative stress result; Nrf2-cytoprotective pathways are upregulated; and these changes help protect against ischemic AKI.


      AKI (acute kidney injury), ARF (acute renal failure), BUN (blood urea nitrogen), FeS (iron sucrose), Fhc (ferritin heavy chain), HO (heme oxygenase), IR (ishcemia reperfusion), IRI (ischemic reperfusion injury), SnPP (tin protoporphyrin)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Translational Research
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Nath K.A.
        Heme oxygenase-1 and acute kidney injury.
        Curr Opin Nephrol Hypertens. 2014; 23: 17-24
        • Ayer A.
        • Zarjou A.
        • Agarwal A.
        • Stocker R.
        Heme oxygenase in cardiovascular health and disease.
        Physiol Rev. 2016; 96: 1449-1508
        • Abraham N.G.
        • Kappas A.
        Pharmacological and clinical aspects of heme oxygenase.
        Pharmacol Rev. 2008; 60: 79-127
        • Kaizu T.
        • Tamaki T.
        • Tanaka M.
        • et al.
        Preconditioning with tin-protoporphyrin IX attenuates ischemia/reperfusion injury in the rat kidney.
        Kidney Int. 2003; 63: 1393-1403
        • Juncos J.P.
        • Grande J.P.
        • Murali N.
        • et al.
        Anomalous renal effects of tin protoporphyrin in a murine model of sickle cell disease.
        Am J Pathol. 2006; 169: 21-31
        • Sutherland B.A.
        • Shaw O.M.
        • Clarkson A.N.
        • et al.
        Tin protoporphyrin provides protection following cerebral hypoxia-ischemia: involvement of alternative pathways.
        J Neurosci Res. 2011; 89: 1284-1294
        • Dennery P.A.
        • Visner G.
        • Weng Y.
        • et al.
        Resistance to hyperoxia with heme oxygenase-1 disruption: role of iron.
        Free Radic Biol Med. 2003; 34: 124-133
        • Zager R.A.
        • Johnson A.C.
        • Frostad K.B.
        Combined iron sucrose and protoporphyrin treatment protects against ischemic and toxin-mediated acute renal failure.
        Kidney Int. 2016; 90: 67-76
        • Zager R.A.
        Marked protection against acute renal and hepatic injury after nitrited myoglobin + tin protoporphyrin administration.
        Transl Res. 2015; 166: 485-501
        • Botros F.T.
        • Prieto-Carrasquero M.C.
        • Martin V.L.
        • Navar L.G.
        Heme oxygenase induction attenuates afferent arteriolar autoregulatory responses.
        Am J Physiol. 2008; 295: F904-F911
        • Kruger A.L.
        • Peterson S.J.
        • Schwartzman M.L.
        • et al.
        Up-regulation of heme oxygenase provides vascular protection in an animal model of diabetes through its antioxidant and antiapoptotic effects.
        J Pharmacol Exp Ther. 2006; 319: 1144-1152
        • Ellman G.L.
        Tissue sulfhydryl groups.
        Arch Biochem Biophys. 1959; 82: 70-77
        • Zager R.A.
        • Schimpf B.A.
        • Bredl C.R.
        • Gmur D.J.
        Inorganic iron effects on in vitro hypoxic proximal renal tubular cell injury.
        J Clin Invest. 1993; 91: 702-708
        • Jeitner T.M.
        Optimized ferrozine-based assay for dissolved iron.
        Anal Biochem. 2014; 454: 36-37
        • Simionatto C.S.
        • Drummond G.S.
        • Landaw S.A.
        • et al.
        Investigations on the role of hemopexin and albumin in plasma clearance and tissue distribution of Sn-protoporphyrin.
        J Lab Clin Med. 1993; 122: 173-179
        • Trapnell C.
        • Pachter L.
        • Salzberg S.L.
        TopHat: discovering splice junctions with RNA-Seq.
        Bioinformatics. 2009; 25: 1105-1111
        • Anders S.
        • Theodor P.P.
        • Huber W.
        HTSeq – a Python framework to work with high-throughput sequencing data.
        Bioinformatics. 2015; 15: 166-169
        • Robinson M.D.
        • McCarthy D.J.
        • Smyth G.K.
        EdgeR- a bioconductor package for differential expression analysis of digital gene expression data.
        Bioinformatics. 2010; 26: 139-140
        • Reiner A.
        • Yekutieli D.
        • Benjamini Y.
        Identifying differentially expressed genes using false discovery rate controlling procedures.
        Bioinformatics. 2003; 19: 368-375
        • R Core Team
        R. A language and environment for statistical computing.
        R Foundation for Statistical Computing, Vienna, Austria2016 (Available at:) (Accessed May 20, 2016)
        • Young M.D.
        • Wakefield M.J.
        • Smyth G.K.
        • Oshlack A.
        Gene ontology analysis for RNA-seq: accounting for selection bias.
        Genome Biol. 2010; 11: R14
        • Zager R.A.
        • Johnson A.C.
        Hanson SY Parenteral iron nephrotoxicity: potential mechanisms and consequences.
        Kidney Int. 2004; 66: 144-156
        • Anderson K.E.
        • Simionatto C.S.
        • Drummond G.S.
        • Kappas A.J.
        Tissue distribution and disposition of tin-protoporphyrin, a potent competitive inhibitor of heme oxygenase.
        Pharmacol Exp Ther. 1984; 228: 327-333
        • Cable E.E.
        • Gildemeister O.S.
        • Pepe J.A.
        • et al.
        Hepatic 5-aminolevulinic acid synthase mRNA stability is modulated by inhibitors of heme biosynthesis and by metalloporphyrins.
        Eur J Biochem. 1996; 15: 112-117
        • Schuurmans M.M.
        • Hoffmann F.
        • Lindberg R.L.
        • Meyer U.A.
        Zinc mesoporphyrin represses induced hepatic 5-aminolevulinic acid synthase and reduces heme oxygenase activity in a mouse model of acute hepatic porphyria.
        Hepatology. 2001; 33: 1217-1222
        • Qiang M.
        Role of Nrf2 in oxidative stress and Toxicity.
        Annu Rev Pharmacol Toxicol. 2013; 53: 401-426
        • Saito H.
        Toxico-pharmacological perspective of the Nrf2-Keap1 defense system against oxidative stress in kidney diseases.
        Biochem Pharmacol. 2013; 85: 865-872
        • Kobayashi M.
        • Yamamoto M.
        Molecular mechanisms activating the Nrf2-Keap1 pathway of antioxidant gene regulation.
        Antioxid Redox Signal. 2005; 7: 385-394
        • Osburn W.O.
        • Kensler T.W.
        Nrf2 signaling: an adaptive response pathway for protection against environmental toxic insults.
        Mutat Res. 2008; 659: 31-39
        • Wakabayashi N.
        • Dinkova-Kostova A.
        • Holtzclaw W.
        • et al.
        Protection against electrophile and oxidant stress by induction of the phase 2 response: fate of cysteines of the Keap1 sensor modified by inducers.
        Proc Natl Acad Sci U S A. 2004; 101: 2040-2045
        • Shelton L.M.
        • Park B.K.
        • Copple I.M.
        Role of Nrf2 in protection against acute kidney injury.
        Kidney Int. 2013; 84: 1090-1095
        • Liu M.
        • Grigoryev D.N.
        • Crow M.T.
        • et al.
        Transcription factor Nrf2 is protective during ischemic and nephrotoxic acute kidney injury in mice.
        Kidney Int. 2009; 76: 277-285
        • Aleksunes L.M.
        • Goedken M.J.
        • Rockwell C.E.
        • et al.
        Transcriptional regulation of renal cytoprotective genes by Nrf2 and its potential use as a therapeutic target to mitigate cisplatin-induced nephrotoxicity.
        J Pharmacol Exp Ther. 2010; 335: 2-12
        • Jiang T.
        • Tian F.
        • Zheng H.
        • et al.
        Nrf2 suppresses lupus nephritis through inhibition of oxidative injury and the NF-κB-mediated inflammatory response.
        Kidney Int. 2014; 85: 333-843
        • Qin Q.
        • Qu C.
        • Niu T.
        • et al.
        Nrf2-mediated cardiac maladaptive remodeling and dysfunction in a setting of autophagy insufficiency.
        Hypertension. 2016; 67: 107-117
        • Mito S.
        • Ozono R.
        • Oshima T.
        • et al.
        Nrf2–-Myocardial protection against pressure overload in mice lacking Bach1, a transcriptional repressor of heme oxygenase-1.
        Hypertension. 2008; 51: 1570-1577
        • Chorley B.N.
        • Campbell M.R.
        • Wang X.
        • et al.
        Identification of novel NRF2-regulated genes by ChIP-Seq: influence on retinoid X receptor alpha.
        Nucleic Acids Res. 2012; 40: 7416-7429
        • Thimmulappa R.K.
        • Mai K.H.
        • Srisuma S.
        • et al.
        Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray.
        Cancer Res. 2002; 62: 5196-5203
        • Reddy N.M.
        • Kleeberger S.R.
        • Yamamoto M.
        • et al.
        Genetic dissection of the Nrf2-dependent redox signaling-regulated transcriptional programs of cell proliferation and cytoprotection.
        Physiol Genomics. 2007; 32: 74-81